Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
元码基因科技(北京)股份有限公司 logo — Harnessing genomics technology to deliver precise medical so...

元码基因科技(北京)股份有限公司

Harnessing genomics technology to deliver precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics.

Founded 2014 16 employees Series A Total: $13.00M Health Care, Information Technology

General Information

Company Name 元码基因科技(北京)股份有限公司
Founded Year 2014
Employees 16
Industries Health Care, Information Technology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with 元码基因科技(北京)股份有限公司. To contact 元码基因科技(北京)股份有限公司, visit geneis.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About 元码基因科技(北京)股份有限公司

Yuancode Gene Technology, founded in 2014, focuses on leveraging genomics technology to provide precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics. The company received a CNY10.00M Series A investment on 07 February 2017 from Source Capital and Tianjin Yahui Mingze Asset Management. Yuancode Gene Technology operates in the Health Care and Information Technology industries, aiming to revolutionize clinical practice with genomics technology. Their slogan encapsulates their mission to harness genomics for targeted medical solutions and innovative cancer treatment platforms.

Taxonomy: genomics technology, precision medicine, clinical cancer platform, bioinformatics, medical solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY10.00M 2
Source Capital
Source Capital, Tianjin Yahui Mingze Asset Management
07 Feb 2017
Angel Round CNY3.00M 2
Huaren Yiyao Peisong, Huaren Chuangtou
15 Mar 2016

元码基因科技(北京)股份有限公司 Alternatives & Competitors

View All Alternatives
元码基因科技(北京)股份有限公司 vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care
元码基因科技(北京)股份有限公司 vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology
元码基因科技(北京)股份有限公司 vs
Strand Life Sciences
Strand Life Sciences India

Personalized Genomics For A Healthier Future

Private Equity
637 employees
Biotechnology, Health Care
View all alternatives

FAQ About 元码基因科技(北京)股份有限公司

Harnessing genomics technology to deliver precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics.
元码基因科技(北京)股份有限公司 was founded in 2014.
元码基因科技(北京)股份有限公司 operates in Health Care and Information Technology. Its work centres on genomics technology, precision medicine, clinical cancer platform and bioinformatics.
元码基因科技(北京)股份有限公司 has approximately 16 employees.
元码基因科技(北京)股份有限公司 has completed 2 funding rounds, raising a total of $13.00M. The latest funding stage is Series A.
Top alternatives and competitors to 元码基因科技(北京)股份有限公司 include ACT Genomics, CureMetrix, Strand Life Sciences, Aidence, Semantic Web India Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
元码基因科技(北京)股份有限公司 and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 元码基因科技(北京)股份有限公司, https://bouncewatch.com/company/cny-4, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes